MMP-12 and TIMP Behavior in Symptomatic and Asymptomatic Critical Carotid Artery Stenosis.

[1]  S. Ye,et al.  Polymorphisms in Matrix Metalloproteinase-1, -3, -9, and -12 Genes in Relation to Subarachnoid Hemorrhage , 2001, Stroke.

[2]  J. Wallace,et al.  Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. , 2002, Blood.

[3]  A. Naylor,et al.  Matrix metalloproteinases and atherosclerotic plaque instability , 2002, The British journal of surgery.

[4]  A. Daugherty,et al.  Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[5]  Yan-hong Guo,et al.  Tissue inhibitor of metalloproteinases-4 suppresses vascular smooth muscle cell migration and induces cell apoptosis. , 2004, Life sciences.

[6]  A. Morgan,et al.  Differences in Matrix Metalloproteinase-1 and Matrix Metalloproteinase-12 Transcript Levels Among Carotid Atherosclerotic Plaques With Different Histopathological Characteristics , 2004, Stroke.

[7]  G. Hansson.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[8]  B. Baxter,et al.  MMP-12 has a role in abdominal aortic aneurysms in mice , 2005 .

[9]  K. Furie,et al.  Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke , 2006, Neurology.

[10]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[11]  R. Virmani,et al.  Pathology of the Vulnerable Plaque , 2006 .

[12]  Y. Sasaguri,et al.  Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits. , 2008, The American journal of pathology.

[13]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[14]  F. Moll,et al.  Carotid Atherosclerotic Plaque Matrix Metalloproteinase-12–Positive Macrophage Subpopulation Predicts Adverse Outcome After Endarterectomy , 2012, Journal of the American Heart Association.

[15]  R. Khalil,et al.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease. , 2012, Experientia supplementum.

[16]  E. Feldmann,et al.  Management Strategies for Asymptomatic Carotid Stenosis , 2013, Annals of Internal Medicine.

[17]  C. Della Rocca,et al.  The Multitasking Role of Macrophages in Stanford Type A Acute Aortic Dissection , 2013, Cardiology.

[18]  Z. Rancic,et al.  Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. , 2014, Nuclear medicine and biology.

[19]  Niku Oksala,et al.  A Novel MMP12 Locus Is Associated with Large Artery Atherosclerotic Stroke Using a Genome-Wide Age-at-Onset Informed Approach , 2014, PLoS genetics.

[20]  L. Rudnicka,et al.  MMP-12 Deficiency Attenuates Angiotensin II-Induced Vascular Injury, M2 Macrophage Accumulation, and Skin and Heart Fibrosis , 2014, PloS one.

[21]  A. Tsiskaridze,et al.  Correlation between MMP-9 and extracellular cytokine HMGB1 in prediction of human ischemic stroke outcome. , 2014, Biochimica et biophysica acta.

[22]  L. Tritapepe,et al.  MMP-12 as a new marker of Stanford-A acute aortic dissection , 2014, Annals of medicine.

[23]  S. Menini,et al.  Loss of TIMP3 exacerbates atherosclerosis in ApoE null mice. , 2014, Atherosclerosis.

[24]  A. Newby.  Metalloproteinases promote plaque rupture and myocardial infarction: A persuasive concept waiting for clinical translation. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[25]  G. Rosenberg,et al.  Matrix metalloproteinases as therapeutic targets for stroke , 2015, Brain Research.

[26]  J. Klopfenstein,et al.  Matrix Metalloproteinase-12 Induces Blood–Brain Barrier Damage After Focal Cerebral Ischemia , 2015, Stroke.

[27]  L. Tritapepe,et al.  Stanford-A acute aortic dissection, inflammation, and metalloproteinases: A review , 2015, Annals of medicine.

[28]  J. Klopfenstein,et al.  Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage , 2015, Scientific Reports.

[29]  I. Gonçalves,et al.  Low Elastin Content of Carotid Plaques Is Associated with Increased Risk of Ipsilateral Stroke , 2015, PloS one.

[30]  A. ElAli,et al.  The Role of Monocytes in Ischemic Stroke Pathobiology: New Avenues to Explore , 2016, Front. Aging Neurosci..

[31]  Mark D. Huffman,et al.  Executive Summary: Heart Disease and Stroke Statistics—2015 Update A Report From the American Heart Association , 2011, Circulation.